Invetech Delivers Organovo’s First Commercial 3D Bio-Printer for Manufacturing Human Tissue and Organs

SAN DIEGO, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--Invetech, an innovator in new product development and custom automation for the biomedical, industrial and consumer markets, today announced that it has delivered the world's first production model 3D bio-printer to Organovo, developers of the proprietary NovoGen bioprinting technology. Organovo will supply the units to research institutions investigating human tissue repair and organ replacement.
MORE ON THIS TOPIC